Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Human Vaccines & Immunotherapeutics|November 11, 2022
Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal diseaseCharu Sabharwal, Vani Sundaraiyer, Yahong Peng, et al.Vaccine|March 13, 2025
A phase 3 study of 20-valent pneumococcal conjugate vaccine in healthy toddlers previously vaccinated in infancy with 13-valent pneumococcal conjugate vaccineFederico Martinón-Torres, Silvina Natalini Martinez, Mary J Kline, et al.Human Vaccines & Immunotherapeutics|August 7, 2023
A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of ageKai Chu, Yuemei Hu, Hongxing Pan, et al.Vaccine|November 4, 2025
Immunogenicity and safety of concomitant vaccines given with 20-valent pneumococcal conjugate vaccine in healthy infantsShelly Senders, Piotr Korbal, Mary Kline, et al.Msphere|August 10, 2018
Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular PolysaccharidesCharles Y Tan, Fred W Immermann, Shite Sebastian, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 19, 2024
A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infantsYasunori Ishihara, Mitsuru Fukazawa, Shinya Enomoto, et al.Vaccine|February 24, 2023
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trialKevin Cannon, Jose F Cardona, Kari Yacisin, et al.The Pediatric Infectious Disease Journal|September 15, 2021
Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United StatesShelly Senders, Nicola P Klein, Erik Lamberth, et al.Scientific Reports|February 7, 2019
Decreased complexity of glucose dynamics in diabetes in rhesus monkeysRichard Raubertas, Jeremy Beech, Wendy Watson, et al.Human Vaccines & Immunotherapeutics|October 11, 2018
Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trialAllison R Thompson, Nicola P Klein, H Jackson Downey, et al.Pageof 6